Encontrados 3 documentos, a visualizar página 1 de 1
Dropout in the treatment of erectile dysfunction with PDE5: a study on predicto...
Carvalheira, A. A.; Pereira, N. M.; Maroco, J.; Forjaz, V.INTRODUCTION: Phosphodiesterase type 5 inhibitors (PDE5) are currently the first line treatment for erectile dysfunction (ED). However, previous research shows that PDE5 treatments have high discontinuation rates. Understanding the reasons for discontinuing PDE5 will be necessary to optimize the response to treatment. AIM: The main goals were: (i) to analyze discontinuation rate of PDE5; (ii) to identify the di...
Independent patterns of damage within magno-, parvo- and koniocellular pathways...
Silva, M. F.; Faria, P.; Regateiro, F. S.; Forjaz, V.; Januário, C.; Freire, A.; Castelo-Branco, M.Sensory deficits have been documented in Parkinson's disease, in particular within the visual domain. However, ageing factors related to the brain and to neural and non-neural ocular structures could explain some of the previously reported results, in particular the claimed impairment within the koniocellular pathway. This study addressed visual impairment attributable to the magno- (luminance), parvo- (red-gre...
Independent patterns of damage within magno-, parvo- and koniocellular pathways...
Silva, MF; Regateiro, FS; Forjaz, V; Januário, C; Freire-Gonçalves, A; Castelo-Branco, MSensory deficits have been documented in Parkinson's disease, in particular within the visual domain. However, ageing factors related to the brain and to neural and non-neural ocular structures could explain some of the previously reported results, in particular the claimed impairment within the koniocellular pathway. This study addressed visual impairment attributable to the magno- (luminance), parvo- (red-gre...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||